Deals, Partnering

Collaboration agreement to initiate multi-center idiopathic pulmonary fibrosis registry and biomarker bank

Posted on 30 January 2014

Tags: , ,

Boehringer Ingelheim Pharmaceuticals and Duke Clinical Research Institute have formed a unique collaborative relationship to uncover insights into idiopathic pulmonary fibrosis.

IPF is a progressive and fatal lung disease.

Boehringer Ingelheim and Duke Clinical Research Institute will initiate a prospective, multi-center IPF registry in the United States, as well as establish a biomarker bank to identify potential blood or genetic markers of the disease that correlate with patient outcomes.

The first project will be the development of the Idiopathic Pulmonary Fibrosis Outcomes Registry (IPF-PRO), a long-term study that will collect and analyze data over time from a large group of patients.


Report: Partnering Agreements with Boehringer Ingelheim 2009-2014

Read: Big pharma deal news - latest deal news for top 50 pharma / big pharma companies

Related report: Partnering Deals and Alliances with Big Pharma

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View:Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View:Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

Signup:Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup:Current Agreements Deals Review – monthly newsletter – reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

Subscribe:Current Agreements life sciences partnering, M&A and financing deals database – find out more

Follow us on:LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter


Print Friendly, PDF & Email

Leave a Reply